Prevalence of High-Risk Human Papillomavirus in Cervical Intraepithelial Neoplasia in the Pre-Vaccine Era - China, 2017-2018

China CDC Wkly. 2022 Dec 2;4(48):1083-1087. doi: 10.46234/ccdcw2022.218.

Abstract

What is already known about this topic?: Human papillomavirus (HPV) type-specific strategies play a key role in the prevention of cervical intraepithelial neoplasia (CIN), but evidence on the HPV type-specific prevalence in CIN is limited.

What is added by this report?: This multicentric study estimates the prevalence of high-risk HPV types in CIN cases and the associations of HPV infection patterns with high-grade CIN in China in 2017-2018.

What are the implications for public health practice?: Population-based prevention strategies should give preference to HPV-16 and 18, and strategies for non-16/18 high-risk HPV are essential for the elimination of cervical cancer.

Keywords: Cervical Intraepithelial Neoplasia; Papillomavirus; Prevalence.

Grants and funding

Chinese Association of Maternal and Child Health Studies (2017AMCHS006) and National Natural Science Foundation of China (81903328)